LGALS3 mediates Aβ deposition by regulating the activation of microglia and induces neuroinflammation and cognitive impairment in AD, and therefore is a key participant in AD pathophysiology (Sethi et al., 2021; Tan et al., 2021). Here, LGALS3 is linked to Alzheimer disease.